NEW HOPE

IN BLADDER CANCER TREATMENT

 
 
VESSI MEDICAL
 

4

TH

75%

2M

300K

 

PATIENT

HEALTH

CARE SYSTEM

PHYSICIAN

PATIENT

PHYSICIAN

HEALTH

CARE SYSTEM

 
 

For Information

Vessi Medical
Misgav Industrial Park
Misgav, Israel

 

 

 


Eyal Kochavi, CEO & Founder
Mail: eyal@vessimed.com
Telephone: +972.52.523.5454

  • White LinkedIn Icon
 

References

1. Babjuk M. Transurethral resection of non–muscle-invasive bladder cancer. European Urology Suppl 2009 8(7):542-548.
2. Traxer O1, Pasqui F, Gattegno B, Pearle MS. Technique and complications of transurethral surgery for bladder tumours. BJU Int. 2004 Sep;94(4):492-6.

3. Kamat AM, Bağcıoğlu M, Huri E. What is new in non-muscle-invasive bladder cancer in 2016 Turk J Urol. 2017 Mar; 43(1): 9–13.

4. Schmidt S et al. Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study. Urol Oncol. 2015 Jan;33(1):19.e7-19.e15. doi.

Vessi Medical logo copy.png